Health News Roundup: China regulator fines two pharma firms for monopoly behaviour

Following is a summary of current health news briefs.

China regulator fines two pharma firms for monopoly behaviour

China's market regulator said on Sunday it had fined two pharmaceutical companies for monopolistic behaviour. It fined Grand Pharmaceutical 136 million yuan ($19.68 million) and confiscated 149 million yuan of "illegal revenue" for entering into a monopolistic deal with Wuhan Healcare Pharmaceuticals.

(With inputs from agencies.)